{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:37:03Z","timestamp":1791005823035,"version":"4.1.0"},"reference-count":68,"publisher":"Oncology Nursing Society (ONS)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Journal of Oncology Nursing"],"published-print":{"date-parts":[[2007,8,1]]},"DOI":"10.1188\/07.cjon.579-589","type":"journal-article","created":{"date-parts":[[2007,8,30]],"date-time":"2007-08-30T10:53:33Z","timestamp":1188471213000},"page":"569-589","source":"Crossref","is-referenced-by-count":6,"title":["The Role of High-Dose Chemotherapy Supported by Hematopoietic Stem Cell Transplantation in Patients With Multiple Myeloma: Implications for Nursing"],"prefix":"10.1188","volume":"11","author":[{"given":"Anna Liza","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Tariman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toreend","family":"Enecio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella Marie","family":"Estrella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1302","published-online":{"date-parts":[[2007,8,27]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.bmt.1701609","article-title":"Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: Analysis of 126 cases","volume":"23","author":"E. Alessandrino","year":"1999","journal-title":"Bone Marrow Transplantation"},{"key":"2","unstructured":"American Association of Blood Banks, America's Blood Centers, American Association of Tissue Banks, American Red Cross, American Society for Apheresis, American Society for Bone and Marrow Transplantation, et al. (2005). Circular of information for the use of cellular products<\/i>. Retrieved October 27, 2006, from http:\/\/www.aabb.org\/Documents\/About_Blood\/Circulars_of_Information\/coi_ct1005.pdf<\/a>"},{"key":"3","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa032290","article-title":"Single versus double autologous stem-cell transplantation for multiple myeloma","volume":"349","author":"M. Attal","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome","volume":"335","author":"M. Attal","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1200\/JCO.20.5.1295","article-title":"Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning","volume":"20","author":"A. Badros","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"6","first-page":"71","article-title":"Bone marrow transplantation in multiple myeloma","volume":"7","author":"B. Barlogie","year":"1991","journal-title":"Bone Marrow Transplantation"},{"key":"7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V89.3.789","article-title":"Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma","volume":"89","author":"B. Barlogie","year":"1997","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1200\/JCO.2005.04.5807","article-title":"Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: Final results of phase III U.S. Intergroup Trial S9321","volume":"24","author":"B. Barlogie","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood-2003-04-1045","article-title":"Treatment of multiple myeloma","volume":"103","author":"B. Barlogie","year":"2004","journal-title":"Blood"},{"key":"10","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1182\/blood-2005-10-4084","article-title":"Total therapy 2 without thalidomide in comparison with total therapy 1: Role of intensified induction and posttransplantation consolidation therapies","volume":"107","author":"B. Barlogie","year":"2006","journal-title":"Blood"},{"key":"11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3816\/CLM.2006.n.027","article-title":"Superior 12-year survival after at least 4-year continuous remission with tandem transplantations for multiple myeloma","volume":"6","author":"B. Barlogie","year":"2006","journal-title":"Clinical Lymphoma and Myeloma"},{"key":"12","unstructured":"Bensinger, W.I. (2005). Allogeneic stem cell transplantation for multiple myeloma. Retrieved June 22, 2006, from http:\/\/professional.cancerconsultants.com\/print.aspx?id=35268<\/a>"},{"key":"13","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1182\/blood.V88.7.2787.bloodjournal8872787","article-title":"Allogeneic marrow transplantation for multiple myeloma: An analysis of risk factors on outcome","volume":"88","author":"W. Bensinger","year":"1996","journal-title":"Blood"},{"key":"14","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1182\/blood-2005-03-1301","article-title":"High-dose therapy intensifi cation compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: Longterm results from a prospective randomized trial from the Spanish Cooperative Group Pethema","volume":"106","author":"J. Blade","year":"2005","journal-title":"Blood"},{"key":"15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","article-title":"Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haematopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant","volume":"102","author":"J. Blade","year":"1998","journal-title":"British Journal of Haematology"},{"key":"16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bmt.1703905","article-title":"Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing","volume":"31","author":"B. Calmels","year":"2003","journal-title":"Bone Marrow Transplantation"},{"key":"17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1182\/blood.V104.11.536.536","article-title":"Superiority of double over single autologous stem cell transplantation as first-line therapy for multiple myeloma [Abstract 536]","volume":"104","author":"M. Cavo","year":"2004","journal-title":"Blood"},{"key":"18","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem cell rescue for multiple myeloma","volume":"348","author":"J. Child","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"Suppl. 1","key":"19","article-title":"Quality of life after an allogeneic bone marrow transplantation: The patient's point of view","volume":"36","author":"J. Claisse","year":"1994","journal-title":"Nouvelle Revue Francaise d'Hematologie"},{"key":"20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1188\/04.CJON.473-480","article-title":"Bortezomib, a newly approved proteasome inhibitor for the treatment of multiple myeloma: Nursing implications","volume":"8","author":"K. Colson","year":"2004","journal-title":"Clinical Journal of Oncology Nursing"},{"key":"21","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1182\/blood-2003-01-0189","article-title":"Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma","volume":"102","author":"P. Corradini","year":"2003","journal-title":"Blood"},{"key":"22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/asheducation-2003.1.419","article-title":"Stem cell mobilization","volume":"2003","author":"M. Cottler-Fox","year":"2003","journal-title":"Hematology"},{"key":"23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma: Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival","volume":"36","author":"B. Durie","year":"1975","journal-title":"Cancer"},{"key":"24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1745-7599.2006.00122.x","article-title":"Common complaints, difficult diagnosis: Multiple myeloma","volume":"18","author":"C. Dvorak","year":"2006","journal-title":"Journal of the American Academy of Nurse Practitioners"},{"key":"25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1365-2141.2003.04299.x","article-title":"Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning","volume":"121","author":"H. Einsele","year":"2003","journal-title":"British Journal of Haematology"},{"key":"26","first-page":"300","article-title":"Myeloma and bone disease: The dangerous tango","volume":"4","author":"J. Epstein","year":"2006","journal-title":"Clinical Advances in Hematology and Oncology"},{"key":"27","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1200\/JCO.2005.03.0551","article-title":"High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: Long-term results of a randomized control trial from the group Myelome-Autogreffe","volume":"23","author":"J. Fermand","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"28","volume-title":"MAG studies","author":"J. Fermand","year":"2005"},{"key":"29","first-page":"313","volume-title":"Clinical bone marrow and blood stem cell transplantation","author":"M. Flowers","year":"2004"},{"key":"30","unstructured":"Foundation for the Accreditation of Hematopoietic Cell Therapy. (1997). FAHCT accreditation manual<\/i>. Omaha, NE: Author."},{"key":"31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.moh.0000182836.40779.e7","article-title":"Progress in hematopoietic stem cell transplantation in multiple myeloma","volume":"12","author":"G. Gahrton","year":"2005","journal-title":"Current Opinion in Hematology"},{"key":"32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2141.2001.02726.x","article-title":"Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: A comparison between transplants performed 1983-93 and 1994-8 at European Group for Blood and Marrow Transplantation Centres","volume":"113","author":"G. Gahrton","year":"2001","journal-title":"British Journal of Haematology"},{"key":"33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/14737140.6.3.343","article-title":"High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma","volume":"6","author":"M. Gertz","year":"2006","journal-title":"Expert Review in Anticancer Therapy"},{"key":"34","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0140-6736(89)91548-1","article-title":"Intensive treatment of multiple myeloma and criteria for complete remission","volume":"2","author":"M. Gore","year":"1989","journal-title":"Lancet"},{"key":"35","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1188\/03.ONF.613-631","article-title":"Quantitative measurement of quality of life in adult patients undergoing bone marrow transplant or peripheral blood stem cell transplant: A decade in review","volume":"30","author":"E. Hacker","year":"2003","journal-title":"Oncology Nursing Forum"},{"key":"36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0885-3924(99)00007-X","article-title":"Fatigue and quality of life in breast cancer patients undergoing autologous stem cell transplantation: A longitudinal comparative study","volume":"17","author":"D. Hann","year":"1999","journal-title":"Journal of Pain and Symptom Management"},{"key":"37","first-page":"1230","article-title":"New questions about transplantation in multiple myeloma","volume":"20","author":"P. Hari","year":"2006","journal-title":"Oncology"},{"key":"38","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/sj.bmt.1702443","article-title":"Neurological events associated with the infusion of cryopreserved bone marrow and\/or peripheral blood progenitor cells","volume":"25","author":"R. Hoyt","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"39","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bmt.1705360","article-title":"High-dose melphalan (200 mg\/m2<\/sup>) supported by autologous stem cell transplantation is safe and effective in elderly (> or = 65 years) myeloma patients: Comparison with younger patients treated on the same protocol","volume":"37","author":"E. Jantunen","year":"2006","journal-title":"Bone Marrow Transplantation"},{"key":"40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"A. Jemal","year":"2007","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"41","volume-title":"Stem cell transplantation: A clinical textbook","author":"P. Kapustay","year":"2005"},{"key":"42","first-page":"223","volume-title":"Myeloma","author":"P. Kelleher","year":"2002"},{"key":"43","first-page":"47","article-title":"Diagnosis and treatment of multiple myeloma in the elderly","volume":"10","author":"R. Kyle","year":"2002","journal-title":"Clinical Geriatrics"},{"key":"44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"R. Kyle","year":"2003","journal-title":"Mayo Clinic Proceedings"},{"key":"45","first-page":"453","volume-title":"Immunoglobulins and laboratory recognition of monoclonal proteins","author":"R. Kyle","year":"1996"},{"key":"46","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"R. Kyle","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"47","volume-title":"Stem cell transplantation: A clinical textbook","author":"B. Letheby","year":"2005"},{"key":"48","first-page":"151","volume-title":"Myeloma","author":"H. Lokhorst","year":"2002"},{"key":"49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.bmt.1701867","article-title":"A quality of life study in 20 adult long-term survivors of unrelated donor bone marrow transplantation","volume":"24","author":"D. Marks","year":"1999","journal-title":"Bone Marrow Transplantation"},{"key":"50","first-page":"43","volume-title":"Hematopoietic stem cell transplantation: A manual for nursing practice","author":"F. McAdams","year":"2005"},{"key":"51","first-page":"579","article-title":"Quality of life in breast cancer patients before and after autologous bone marrow transplantation","volume":"18","author":"R. McQuellon","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"52","unstructured":"National Comprehensive Cancer Network. (2005). NCCN 2005 multiple myeloma clinical practice guidelines in oncology. The complete library of NCCN clinical practice guidelines in oncology<\/i> [CD-ROM]. Jenkintown, PA: Author."},{"key":"53","first-page":"13","volume-title":"Hematopoietic stem cell transplantation: A manual for nursing practice","author":"D. Niess","year":"2004"},{"key":"54","unstructured":"Northwestern Memorial Hospital. (2001). Hematopoietic stem cell transplant program: Mobilization and apheresis for autologous transplantation<\/i>. Chicago: Author."},{"key":"55","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/cncr.21342","article-title":"Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma","volume":"104","author":"A. Palumbo","year":"2005","journal-title":"Cancer"},{"key":"56","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2004-02-0408","article-title":"Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: Results of a randomized controlled trial","volume":"104","author":"A. Palumbo","year":"2004","journal-title":"Blood"},{"key":"57","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4065\/77.8.813","article-title":"Current therapy for multiple myeloma","volume":"77","author":"S. Rajkumar","year":"2002","journal-title":"Mayo Clinic Proceedings"},{"key":"58","first-page":"3","volume-title":"Myeloma","author":"S. Rajkumar","year":"2002"},{"key":"59","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/sj.bmt.1705392","article-title":"Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma","volume":"37","author":"S. Saraf","year":"2006","journal-title":"Bone Marrow Transplantation"},{"key":"60","first-page":"23","volume-title":"Hematopoietic stem cell transplantation: A manual for nursing practice","author":"K. Schmit-Pokorny","year":"2004"},{"key":"61","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood-2002-03-0889","article-title":"Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: A prospective randomized phase 3 study","volume":"101","author":"C. Segeren","year":"2003","journal-title":"Blood"},{"key":"62","first-page":"327","volume-title":"Myeloma","author":"S. Singhal","year":"2002"},{"key":"63","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1188\/03.CJON.143-147","article-title":"Thalidomide: Current therapeutic uses and management of its toxicities","volume":"7","author":"J. Tariman","year":"2003","journal-title":"Clinical Journal of Oncology Nursing"},{"key":"64","first-page":"1460","volume-title":"Cancer nursing: Principles and practice","author":"J. Tariman","year":"2005"},{"key":"65","doi-asserted-by":"crossref","unstructured":"Tariman, J.D., & Estrella, S.M. (2005). The changing treatment paradigm in patients with newly diagnosed multiple myeloma: Implications for nursing [Online exclusive]. Oncology Nursing Forum<\/i>, 32, E127--E138. Retrieved July 3, 2007, from http:\/\/www.ons.org\/publications\/journals\/ONF\/Volume32\/Issue6\/pdf\/32061098.pdf<\/a>","DOI":"10.1188\/05.ONF.E127-E138"},{"key":"66","volume-title":"A pilot study on QOL post-autologous stem cell transplant (ASCT) in older adults","author":"J. Tariman","year":"2006"},{"key":"67","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/sj.bmt.1705100","article-title":"Variation in dimethyl sulfoxide use in stem cell transplantation: A survey of EBMT centres","volume":"36","author":"P. Windrum","year":"2005","journal-title":"Bone Marrow Transplantation"},{"key":"68","first-page":"478","volume-title":"Cancer nursing: Principles and practice","author":"D. Wujcik","year":"2005"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/36K8X85141442644.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:51:06Z","timestamp":1763754666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/11\/4\/role-high-dose-chemotherapy-supported-hematopoietic-stem-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,1]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8,1]]}},"alternative-id":["36K8X85141442644"],"URL":"https:\/\/doi.org\/10.1188\/07.cjon.579-589","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"value":"1092-1095","type":"print"},{"value":"1538-067X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,1]]}}}